IBP Stock Forecast & Price Target

Installed Building Prods is viewed favorably because its commercial business is providing an important offset to residential weakness, with commercial sales up 16.2% y/y, same-branch sales up 10.3%, and a double-digit backlog that should support growth into 2027. The company also delivered 2Q adj. EPS of $2.91 and adj. EBITDA of $131M, both ahead of consensus, while disciplined pricing and stickier spray foam increases should help protect margins despite softer single-family demand. Further upside comes from lower rates, incremental margin improvement, and M&A, alongside management’s ability to partially offset weaker residential trends through diversified end markets and complementary building products.

Installed Building Prods is facing a deteriorating fundamental setup as weak residential new construction, especially its high-exposure new single-family business, is pressuring volumes and likely to persist into '27, with public builder revenue already about -7% in 3Q and guides implying another -6% in 4Q. Despite solid heavy commercial growth of roughly +13% y/y and robust backlogs, that offset is not enough to absorb lower residential demand, tougher comps, and the risk of softer starts, so FY’26E/'27E Adj. EBITDA has been cut to $468/$451 MM. Margins are also under strain from aluminum, fuel, freight, and mix headwinds, driving gross margin down to 31.9% in 3Q and implying FY’27E Adj. EBITDA margin of 15.2% versus 16.4% previously.